Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1973 Sep;66(9):897–900. doi: 10.1177/003591577306600932

Drug-induced nephropathies.

H C Burry
PMCID: PMC1645430  PMID: 4805093

Full text

PDF
897

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANGERVALL L., LEHMANN L., BENGTSSON U. THE RENAL CONCENTRATING CAPACITY IN ALBINO RATS AFTER LONG-TERM CONSUMPTION OF PHENACETIN, NAPA (N-ACETYL-P-AMINOPHENOL) AND ACETYLSALICYLIC ACID. Acta Med Scand. 1964 Feb;175:155–160. doi: 10.1111/j.0954-6820.1964.tb00561.x. [DOI] [PubMed] [Google Scholar]
  2. BRUN C., OLSEN S., RAASCHOU F., SORENSEN A. W. THE LOCALIZATION OF GOLD IN THE HUMAN KIDNEY FOLLOWING CHRYSOTHERAPY: A BIOPSY STUDY. Nephron. 1964;1:265–276. doi: 10.1159/000179340. [DOI] [PubMed] [Google Scholar]
  3. Bengtsson U., Angervall L., Ekman H., Lehmann L. Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol. 1968;2(3):145–150. doi: 10.3109/00365596809135358. [DOI] [PubMed] [Google Scholar]
  4. Brown D. M., Hardy T. L. Short-term study of the effect of phenacetin, phenazone and amidopyrine on the rat kidney. Br J Pharmacol Chemother. 1968 Jan;32(1):17–24. doi: 10.1111/j.1476-5381.1968.tb00424.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bulger R. J., Healey L. A., Polinsky P. Renal abnormalities in rheumatoid arthritis. Ann Rheum Dis. 1968 Jul;27(4):339–344. doi: 10.1136/ard.27.4.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burry A. F. A profile of renal disease in Queensland: results of an autopsy survey. Med J Aust. 1966 May 14;1(20):826–834. doi: 10.5694/j.1326-5377.1966.tb72874.x. [DOI] [PubMed] [Google Scholar]
  7. Burry A. F. The evolution of analgesic nephropathy. Nephron. 1968;5(3):185–201. doi: 10.1159/000179629. [DOI] [PubMed] [Google Scholar]
  8. Burry H. C. Bacteriuria in rheumatoid arthritis. Ann Rheum Dis. 1973 May;32(3):208–211. doi: 10.1136/ard.32.3.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Burry H. C. Reduced glomerular function in rheumatoid arthritis. Ann Rheum Dis. 1972 Jan;31(1):65–68. doi: 10.1136/ard.31.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Controlled trial of D(-)penicillamine in severe rheumatoid arthritis. Lancet. 1973 Feb 10;1(7798):275–280. [PubMed] [Google Scholar]
  11. DEROT M., KAHN J., MAZALTON A., PEYRAFORT J. Néphrite anurique aiguë mortelle après traitement aurique, chrysocyanose associée. 1954 Feb 26-Mar 5Bull Mem Soc Med Hop Paris. 70(7-8):234–239. [PubMed] [Google Scholar]
  12. DUTHIE J. J., BROWN P. E., TRUELOVE L. H., BARAGAR F. D., LAWRIE A. J. COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT. Ann Rheum Dis. 1964 May;23:193–204. doi: 10.1136/ard.23.3.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fairley K. F., Kincaid-Smith P. Renal papillary necrosis with a normal pyelogram. Br Med J. 1968 Jan 20;1(5585):156–157. doi: 10.1136/bmj.1.5585.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Felts J. H., King J. S., Boyce W. H. Nephrotic syndrome after treatment with D-penicillamine. Lancet. 1968 Jan 6;1(7532):53–54. doi: 10.1016/s0140-6736(68)90057-3. [DOI] [PubMed] [Google Scholar]
  15. Fraser T. N. Gold Treatment in Rheumatoid Arthritis. Ann Rheum Dis. 1945 Jun;4(4):71–75. doi: 10.1136/ard.4.4.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Freyberg R. H., Block W. D., Levey S. Metabolism, Toxicity and Manner of Action of Gold Compounds used in the Treatment of Arthritis: Complete Excretion Studies and Comparison of Intravenous and Intramuscular administration of Some Gold Salts. Ann Rheum Dis. 1942 Dec;3(2):77–89. doi: 10.1136/ard.3.2.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HEIDELMANN G., HUTH J., KOCH E. Uber Nierenfunktionsstörungen bei chronischer Polyarthritis. Z Rheumaforsch. 1956 Aug;15(7-8):208–219. [PubMed] [Google Scholar]
  18. Huskisson E. C., Hart F. D. Penicillamine in the treatment of rheumatoid arthritis. Ann Rheum Dis. 1972 Sep;31(5):402–404. doi: 10.1136/ard.31.5.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hándlová D. Ledvinové komplikace lécby zlatem u progresivní polyartritidy. Vnitr Lek. 1968 Feb;14(2):115–118. [PubMed] [Google Scholar]
  20. Jaffe I. A. The effect of penicillamine on the laboratory parameters in rheumatoid arthritis. Arthritis Rheum. 1965 Dec;8(6):1064–1079. doi: 10.1002/art.1780080606. [DOI] [PubMed] [Google Scholar]
  21. Jaffe I. A., Treser G., Suzuki Y., Ehrenreich T. Nephropathy induced by D-penicillamine. Ann Intern Med. 1968 Sep;69(3):549–556. doi: 10.7326/0003-4819-69-3-549. [DOI] [PubMed] [Google Scholar]
  22. Kennedy A., Saluga P. G. Urinary cytology in experimental toxic renal injury. Ann Rheum Dis. 1970 Sep;29(5):546–552. doi: 10.1136/ard.29.5.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kincaid-Smith P. Analgesic nephropathy and papillary necrosis. Postgrad Med J. 1968 Oct;44(516):807–810. doi: 10.1136/pgmj.44.516.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Krikler D. M. Paracetamol and the kidney. Br Med J. 1967 Jun 3;2(5552):615–616. doi: 10.1136/bmj.2.5552.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. LEE J. C., DUSHKIN M., EYRING E. J., ENGLEMAN E. P., HOPPER J., Jr RENAL LESIONS ASSOCIATED WITH GOLD THERAPY; LIGHT AND ELECTRON MICROSCOPIC STUDIES. Arthritis Rheum. 1965 Feb;8:1–13. doi: 10.1002/art.1780080102. [DOI] [PubMed] [Google Scholar]
  26. Lawson A. A., Maclean N. Renal disease and drug therapy in rheumatoid arthritis. Ann Rheum Dis. 1966 Sep;25(5):441–449. doi: 10.1136/ard.25.5.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Leathwood P. D., Plummer D. T. The excretion of lacate dehydrogenase in human urine after he ingestion of aspiin. Biochem J. 1969 Sep;114(2):197–202. doi: 10.1042/bj1140197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. PRESCOTT L. F. EFFECTS OF ACETYLSALICYLIC ACID, PHENACETIN, PARACETAMOL, AND CAFFEINE ON RENAL TUBULAR EPITHELIUM. Lancet. 1965 Jul 17;2(7403):91–95. doi: 10.1016/s0140-6736(65)92216-6. [DOI] [PubMed] [Google Scholar]
  29. RICHARDSON J. H., ALDERFER H. H. Acute renal failure caused by phenylbutazone. N Engl J Med. 1963 Apr 11;268:809–811. doi: 10.1056/NEJM196304112681503. [DOI] [PubMed] [Google Scholar]
  30. SCHNITZER B., SMITH E. B., GOLDEN A. THE EFFECTS OF PHENACETIN AND ITS CONTAMINANT ON THE KIDNEY OF THE RAT. Am J Pathol. 1965 Jun;46:917–927. [PMC free article] [PubMed] [Google Scholar]
  31. SORENSEN A. W. THE KIDNEY FUNCTION IN RELATION TO DRUG CONSUMPTION IN PATIENTS WITH RHEUMATOID ARTHRITIS. (V). Acta Rheumatol Scand. 1963;9:122–140. doi: 10.3109/rhe1.1963.9.issue-1-4.17. [DOI] [PubMed] [Google Scholar]
  32. Saker B. M., Kincaid-Smith P. Papillary necrosis in experimental analgesic nephropathy. Br Med J. 1969 Jan 18;1(5637):161–162. doi: 10.1136/bmj.1.5637.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shelley J. H. Phenacetin, through the looking glass. Clin Pharmacol Ther. 1967 May-Jun;8(3):427–471. doi: 10.1002/cpt196783427. [DOI] [PubMed] [Google Scholar]
  34. Silverberg D. S., Kidd E. G., Shnitka T. K., Ulan R. A. Gold nephropathy. A clinical and pathologic study. Arthritis Rheum. 1970 Nov-Dec;13(6):812–825. doi: 10.1002/art.1780130611. [DOI] [PubMed] [Google Scholar]
  35. Steele T. W., Györy A. Z., Edwards K. D. Renal function in analgesic nephropathy. Br Med J. 1969 Apr 26;2(5651):213–216. doi: 10.1136/bmj.2.5651.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stoeber E., Sänger L., Kölle G. Indometacin-Behandlung der juvenilen rheumatoiden Arthritis (chronische Polyarthritis) Munch Med Wochenschr. 1968 Mar 1;110(9):548–551. [PubMed] [Google Scholar]
  37. Sänger L., Stoeber E., Kölle G. Langzeittherapie mit Indometacin bei der juvenilen rheumatoiden Arthritis und beim Morbus Still. Arzneimittelforschung. 1967 Nov;17(11):1414–1420. [PubMed] [Google Scholar]
  38. THURAU K. RENAL HEMODYNAMICS. Am J Med. 1964 May;36:698–719. doi: 10.1016/0002-9343(64)90181-0. [DOI] [PubMed] [Google Scholar]
  39. Thomas J. P., Coles G. A., el-Shaboury A. H. Nocturia in patients on long-term steroid therapy. Clin Sci. 1970 Apr;38(4):415–425. doi: 10.1042/cs0380415. [DOI] [PubMed] [Google Scholar]
  40. WALSHE J. M. Wilson's disease; new oral therapy. Lancet. 1956 Jan 7;270(6906):25–26. doi: 10.1016/s0140-6736(56)91859-1. [DOI] [PubMed] [Google Scholar]
  41. Wilkinson R., Eccleston D. W. Nephrotic syndrome induced by gold therapy. Br Med J. 1970 Jun 27;2(5712):772–772. doi: 10.1136/bmj.2.5712.772. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES